Developer docs
API playgroundTry for free, no card

Search company profiles

PharmaForce International

Full company profile

uuid000bcei

Namestring
PharmaForce International
Legal namestring
PharmaForce International, Inc.
Company typeenum
Private
Founded yearint
1995
Descriptiontext

PharmaForce International is a privately held pharmaceutical and biotech competitive intelligence firm headquartered in Reading, Pennsylvania, with operations spanning the United States, Europe (including EU5 markets and Switzerland), Japan, India, and Latin America. Founded in 1995 and operating with 60+ employees worldwide, the company sells subscription-based intelligence products and custom research to global pharmaceutical companies, mid-size pharma organizations, and small-to-mid biotech firms seeking commercial operations benchmarking.

The company's core offering is the Global Deployment Analyzer, a web-based database that captures over 80% of field force headcount across approximately 70 organizations in the United States, with region-specific editions for Europe, India, Japan, and Latin America. This product is supported by a syndicated report library covering therapeutic areas including oncology, immunology, biosimilars, multiple sclerosis, hemophilia, migraine, medical liaison, managed markets, and digital marketing, updated on 12-18 month cycles. Underlying data is produced through a proprietary primary research methodology: multi-lingual analysts conduct one-on-one interviews with industry personnel, and findings undergo a documented triangulation process across multiple sources before publication. The firm operates a wholly-owned India subsidiary, PharmaForce Reports Pvt. Ltd., and supports its products through a web-based client portal.

Revenue is generated through three streams: recurring subscriptions to the Global Deployment Analyzer and syndicated reports (priced annually with global enterprise licenses included), custom research projects sold via direct engagement, and ancillary interactive tools such as the Oncology FTE Trend Analysis Dashboard. The go-to-market is sales-led enterprise direct, supplemented by inbound inquiry capture, with brand presence built through industry conference participation (eyeforpharma, Pharma CI, ASCO), webinars, and a press release cadence. Pricing is quote-based and not publicly disclosed. Leadership includes CEO and co-founder Daniel Dimitri, Chief Product Officer Anthony Velasquez, and Chief Architect Kareem Khan.

Short descriptiontext

PharmaForce International is a privately held pharmaceutical competitive intelligence firm that sells subscription-based syndicated reports, the Global Deployment Analyzer database, and custom research to global pharma, mid-size pharma, and biotech companies across the US, Europe, Japan, India, and Latin America.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersReading, United States
HQ citystring
Reading
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical competitive intelligence, sales force deployment, therapeutic area benchmarking, pharmaceutical market research, commercial operations analytics
NAICS code2 codes
  • Management Consulting Services54161
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical Competitive Intelligence
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Syndicated Reports Subscription
TypeSubscription Recurring
Description

Subscription-based access to pre-packaged competitive intelligence reports covering specific therapeutic areas. Reports are published/updated every 12-18 months. Includes oncology, immunology, biosimilars, multiple sclerosis, hemophilia, migraine, medical liaison, managed markets, and more.

2Deployment Analyzer Subscription
TypeSubscription Recurring
Description

Web-based subscription database providing real-time access to competitor sales force headcounts, FTEs, compensation, call reach and frequency, and physician target audience data. Region-specific editions for US, Europe, and other markets.

3Custom Research Projects
TypeProfessional Services
Description

Proprietary custom market intelligence projects tailored to specific client needs for therapeutic areas, markets, or competitors not covered in syndicated offerings. Timelines and delivery schedules discussed within proposals.

Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Pricing details1 tier
1Syndicated Reports - per report/annual subscription
ModelSubscriptionBilling cadenceAnnual
Notes

Syndicated reports typically range in topics like Oncology, Immunology, Hemophilia, Biosimilars, Multiple Sclerosis, MSL, and Managed Markets. Updated every 12-18 months.

GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

PharmaForce International is a pharmaceutical competitive intelligence firm that sells syndicated benchmarking reports and a subscription-based web platform called the Global Deployment Analyzer. The Global Deployment Analyzer provides real-time data on competitor sales force headcounts, FTEs, compensation, call reach and frequency, and physician target audiences across the US, Europe, India, Latin America, and Japan. The company also offers proprietary custom research services tailored to specific client needs in therapeutic areas not covered by syndicated offerings.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 80%+ field force headcount coverage across approximately 70 organizations in the United States market
+1 more record
Product overview1 text field

PharmaForce International offers a portfolio of pharmaceutical competitive intelligence products centered around two core offerings: the Global Deployment Analyzer, a web-based sales force deployment database covering US, Europe, India and Latin America markets that captures over 80% of field force headcount; and a library of syndicated benchmarking reports covering therapeutic areas including Oncology, Immunology, Multiple Sclerosis, Biosimilars, Hemophilia, Migraine, Parkinson's/Alzheimer's, Cardiovascular/Diabetes, HIV/HCV/HBV, and Managed Markets. The company also provides Custom Research Services for proprietary market intelligence and an Interactive Dashboard for FTE trend analysis. All services are accessed through the Client Portal.

Product and service5 records
1Global Deployment Analyzer
CategoryCompetitive Intelligence Platform
Description

Web-based subscription database providing real-time access to competitor sales force headcounts, FTEs, compensation, call reach and frequency, and physician target audiences. Region-specific editions available for the US and Europe; coverage extends to India, Latin America, and Japan.

2Oncology Syndicated Reports
CategorySyndicated Benchmarking Report
Description

In-depth benchmarking reports analyzing sales and marketing activities supporting key oncology brands, covering organizational structures, commercial operations, and competitive positioning. Reports updated every 12-18 months.

3Immunology Syndicated Reports
CategorySyndicated Benchmarking Report
Description

Commercial operations benchmarking reports covering leading US and EU immunology organizations, including organizational structures, field medical teams, sales representative deployment, and sales approach shifts.

4Medical Liaison Syndicated Reports
CategorySyndicated Benchmarking Report
Description

Benchmarking reports describing pharmaceutical companies' strategies for leveraging medical liaisons and similar field medical personnel, including organizational structures and activity profiles.

5Multiple Sclerosis Sales and Marketing Reports
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

IQVIA is the largest life sciences commercial intelligence and R&D services provider, offering sales force deployment data, market analytics, and benchmarking across pharma and biotech. It competes with PharmaForce primarily through its broader commercial analytics suite that overlaps with the Deployment Analyzer and syndicated benchmarking.

TypeBroad incumbent
Description

Clarivate (through Cortellis, Citeline, and DRG) provides pharma competitive intelligence, market forecasts, and commercial benchmarking. It is comparable because it sells subscription-based intelligence products to the same Top 10 pharma and biotech customers that PharmaForce serves.

TypeDirect peer
Description

GlobalData provides syndicated pharma market intelligence, company pipeline analytics, and commercial benchmarking reports. Its subscription-based competitive intelligence model and therapeutic area coverage overlap directly with PharmaForce's syndicated reports and Deployment Analyzer.

TypeDirect peer
Description

Informa Pharma Intelligence (Citeline, Trialtrove, Datamonitor Healthcare) offers competitive intelligence, clinical trial analytics, and commercial strategy research to pharma clients. The subscription model, therapeutic area depth, and customer overlap make it one of the closest direct peers to PharmaForce.

5ZS Associates
TypeDirect peer
Description

ZS Associates is a global consulting firm specializing in pharmaceutical sales and marketing, including sales force sizing, deployment analytics, and incentive compensation. Its commercial operations practice directly overlaps with PharmaForce's Deployment Analyzer and benchmarking work.

6Trinity Partners
TypeDirect peer
Description

Trinity Partners is a life sciences consulting firm providing commercial strategy, market access, and competitive intelligence for pharma and biotech. It is comparable because it serves the same enterprise pharma buyer with bespoke market intelligence projects similar to PharmaForce's Custom Research offering.

TypeDirect peer
Description

Best Practices LLC delivers benchmarking and best practices research to pharma executives across commercial operations, medical affairs, and market access. Its subscription benchmarking reports directly parallel PharmaForce's syndicated report catalog in structure and customer base.

TypeBroad incumbent
Description

Syneos Health provides commercialization services including consulting on sales force effectiveness, market access, and competitive strategy for pharma. Its consulting arm overlaps with PharmaForce's commercial operations benchmarking and custom research work.

TypeEmerging player
Description

Definitive Healthcare offers commercial intelligence and analytics for healthcare and life sciences, including sales force and market access data. It is a partially overlapping emerging player with growing subscription-based competitive intelligence offerings aimed at pharma.

TypeEmerging player
Description

CMI Media Group provides media planning, market research, and competitive insights for pharmaceutical marketing teams. It is comparable as an emerging player serving the same pharma marketing and sales leadership buyers with adjacent competitive intelligence offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PharmaForce International

Pharmaceutical Competitive Intelligencepharmaforceintl.com

PharmaForce International is a privately held pharmaceutical competitive intelligence firm that sells subscription-based syndicated reports, the Global Deployment Analyzer database, and custom research to global pharma, mid-size pharma, and biotech companies across the US, Europe, Japan, India, and Latin America.

What PharmaForce International does

PharmaForce International is a privately held pharmaceutical and biotech competitive intelligence firm headquartered in Reading, Pennsylvania, with operations spanning the United States, Europe (including EU5 markets and Switzerland), Japan, India, and Latin America. Founded in 1995 and operating with 60+ employees worldwide, the company sells subscription-based intelligence products and custom research to global pharmaceutical companies, mid-size pharma organizations, and small-to-mid biotech firms seeking commercial operations benchmarking.

The company's core offering is the Global Deployment Analyzer, a web-based database that captures over 80% of field force headcount across approximately 70 organizations in the United States, with region-specific editions for Europe, India, Japan, and Latin America. This product is supported by a syndicated report library covering therapeutic areas including oncology, immunology, biosimilars, multiple sclerosis, hemophilia, migraine, medical liaison, managed markets, and digital marketing, updated on 12-18 month cycles. Underlying data is produced through a proprietary primary research methodology: multi-lingual analysts conduct one-on-one interviews with industry personnel, and findings undergo a documented triangulation process across multiple sources before publication. The firm operates a wholly-owned India subsidiary, PharmaForce Reports Pvt. Ltd., and supports its products through a web-based client portal.

Revenue is generated through three streams: recurring subscriptions to the Global Deployment Analyzer and syndicated reports (priced annually with global enterprise licenses included), custom research projects sold via direct engagement, and ancillary interactive tools such as the Oncology FTE Trend Analysis Dashboard. The go-to-market is sales-led enterprise direct, supplemented by inbound inquiry capture, with brand presence built through industry conference participation (eyeforpharma, Pharma CI, ASCO), webinars, and a press release cadence. Pricing is quote-based and not publicly disclosed. Leadership includes CEO and co-founder Daniel Dimitri, Chief Product Officer Anthony Velasquez, and Chief Architect Kareem Khan.

PharmaForce International firmographics

Firmographics
Name
PharmaForce International
Legal name
PharmaForce International, Inc.
Website
https://pharmaforceintl.com
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
51–100 employees
Short description
PharmaForce International is a privately held pharmaceutical competitive intelligence firm that sells subscription-based syndicated reports, the Global Deployment Analyzer database, and custom research to global pharma, mid-size pharma, and biotech companies across the US, Europe, Japan, India, and Latin America.
Ownership category
akta.pro rank

Where PharmaForce International is headquartered

Location

Headquarters

HQ city
Reading
HQ country
United States
HQ region
North America

Offices2 records

Markets served

PharmaForce International business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Syndicated Reports Subscription: Subscription-based access to pre-packaged competitive intelligence reports covering specific therapeutic areas. Reports are published/updated every 12-18 months. Includes oncology, immunology, biosimilars, multiple sclerosis, hemophilia, migraine, medical liaison, managed markets, and more.
  2. Deployment Analyzer Subscription: Web-based subscription database providing real-time access to competitor sales force headcounts, FTEs, compensation, call reach and frequency, and physician target audience data. Region-specific editions for US, Europe, and other markets.
  3. Custom Research Projects: Proprietary custom market intelligence projects tailored to specific client needs for therapeutic areas, markets, or competitors not covered in syndicated offerings. Timelines and delivery schedules discussed within proposals.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualSyndicated Reports - per report/annual subscription

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

PharmaForce International product offering

Product offering

Core offering

PharmaForce International is a pharmaceutical competitive intelligence firm that sells syndicated benchmarking reports and a subscription-based web platform called the Global Deployment Analyzer. The Global Deployment Analyzer provides real-time data on competitor sales force headcounts, FTEs, compensation, call reach and frequency, and physician target audiences across the US, Europe, India, Latin America, and Japan. The company also offers proprietary custom research services tailored to specific client needs in therapeutic areas not covered by syndicated offerings.

Product overview

PharmaForce International offers a portfolio of pharmaceutical competitive intelligence products centered around two core offerings: the Global Deployment Analyzer, a web-based sales force deployment database covering US, Europe, India and Latin America markets that captures over 80% of field force headcount; and a library of syndicated benchmarking reports covering therapeutic areas including Oncology, Immunology, Multiple Sclerosis, Biosimilars, Hemophilia, Migraine, Parkinson's/Alzheimer's, Cardiovascular/Diabetes, HIV/HCV/HBV, and Managed Markets. The company also provides Custom Research Services for proprietary market intelligence and an Interactive Dashboard for FTE trend analysis. All services are accessed through the Client Portal.

Differentiator

Problem solved

Functional benefit

Products and services

  • Global Deployment Analyzer Web-based subscription database providing real-time access to competitor sales force headcounts, FTEs, compensation, call reach and frequency, and physician target audiences. Region-specific editions available for the US and Europe; coverage extends to India, Latin America, and Japan.
  • Oncology Syndicated Reports In-depth benchmarking reports analyzing sales and marketing activities supporting key oncology brands, covering organizational structures, commercial operations, and competitive positioning. Reports updated every 12-18 months.
  • Immunology Syndicated Reports Commercial operations benchmarking reports covering leading US and EU immunology organizations, including organizational structures, field medical teams, sales representative deployment, and sales approach shifts.
  • Medical Liaison Syndicated Reports Benchmarking reports describing pharmaceutical companies' strategies for leveraging medical liaisons and similar field medical personnel, including organizational structures and activity profiles.
  • Multiple Sclerosis Sales and Marketing Reports

Quantifiable outcome

  • 80%+ field force headcount coverage across approximately 70 organizations in the United States market
  • +1 more outcomes

Companies that use PharmaForce International

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

PharmaForce International technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

PharmaForce International partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves7 records

Expansion highlights4 records

PharmaForce International competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA is the largest life sciences commercial intelligence and R&D services provider, offering sales force deployment data, market analytics, and benchmarking across pharma and biotech. It competes with PharmaForce primarily through its broader commercial analytics suite that overlaps with the Deployment Analyzer and syndicated benchmarking.
  • Clarivate: Clarivate (through Cortellis, Citeline, and DRG) provides pharma competitive intelligence, market forecasts, and commercial benchmarking. It is comparable because it sells subscription-based intelligence products to the same Top 10 pharma and biotech customers that PharmaForce serves.
  • Syneos Health Consulting: Syneos Health provides commercialization services including consulting on sales force effectiveness, market access, and competitive strategy for pharma. Its consulting arm overlaps with PharmaForce's commercial operations benchmarking and custom research work.

Direct peers

  • GlobalData: GlobalData provides syndicated pharma market intelligence, company pipeline analytics, and commercial benchmarking reports. Its subscription-based competitive intelligence model and therapeutic area coverage overlap directly with PharmaForce's syndicated reports and Deployment Analyzer.
  • Informa Pharma Intelligence: Informa Pharma Intelligence (Citeline, Trialtrove, Datamonitor Healthcare) offers competitive intelligence, clinical trial analytics, and commercial strategy research to pharma clients. The subscription model, therapeutic area depth, and customer overlap make it one of the closest direct peers to PharmaForce.
  • ZS Associates: ZS Associates is a global consulting firm specializing in pharmaceutical sales and marketing, including sales force sizing, deployment analytics, and incentive compensation. Its commercial operations practice directly overlaps with PharmaForce's Deployment Analyzer and benchmarking work.
  • Trinity Partners: Trinity Partners is a life sciences consulting firm providing commercial strategy, market access, and competitive intelligence for pharma and biotech. It is comparable because it serves the same enterprise pharma buyer with bespoke market intelligence projects similar to PharmaForce's Custom Research offering.
  • Best Practices LLC: Best Practices LLC delivers benchmarking and best practices research to pharma executives across commercial operations, medical affairs, and market access. Its subscription benchmarking reports directly parallel PharmaForce's syndicated report catalog in structure and customer base.

Emerging players

  • Definitive Healthcare: Definitive Healthcare offers commercial intelligence and analytics for healthcare and life sciences, including sales force and market access data. It is a partially overlapping emerging player with growing subscription-based competitive intelligence offerings aimed at pharma.
  • CMI Media Group: CMI Media Group provides media planning, market research, and competitive insights for pharmaceutical marketing teams. It is comparable as an emerging player serving the same pharma marketing and sales leadership buyers with adjacent competitive intelligence offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

PharmaForce International social profiles

Digital presence

PharmaForce International financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PharmaForce International leadership team

Management profile

Number of profiles

Profiles3 records

PharmaForce International subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

PharmaForce International funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PharmaForce International M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmaForce International

What does PharmaForce International do?

PharmaForce International is a pharmaceutical competitive intelligence firm that sells syndicated benchmarking reports and a subscription-based web platform called the Global Deployment Analyzer. The Global Deployment Analyzer provides real-time data on competitor sales force headcounts, FTEs, compensation, call reach and frequency, and physician target audiences across the US, Europe, India, Latin America, and Japan. The company also offers proprietary custom research services tailored to specific client needs in therapeutic areas not covered by syndicated offerings.

Is PharmaForce International a public or private company?

PharmaForce International is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was PharmaForce International founded?

PharmaForce International was founded in 1995. It employs 51 to 100 people.

Where is PharmaForce International based?

PharmaForce International is headquartered in Reading, United States, in the North America region.

How does PharmaForce International make money?

Three revenue lines are on record. Syndicated Reports Subscription is the primary driver. The others are deployment Analyzer Subscription and custom Research Projects.

Who are PharmaForce International's main competitors?

Broad incumbents on record are IQVIA, Clarivate and Syneos Health Consulting. Direct peers are GlobalData, Informa Pharma Intelligence, ZS Associates, Trinity Partners and Best Practices LLC. Emerging players are Definitive Healthcare and CMI Media Group.

Does PharmaForce International have an API?

No public API is recorded for PharmaForce International.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePharmaForce International: Leading Oncology Companies in Europe Make Key Changes to Commercial Affairs Personnel in 2023PharmaForce International published competitive intelligence reports in June 2023 benchmarking commercial operations and marketing expenditures of leading Oncology organizations across France, Germany, Italy, Spain, and the United Kingdom. The reports found notable staffing shifts, including increases in Medical and Market Access personnel across all five countries (France saw over 100% growth in Market Access personnel), while Sales personnel decreased or remained flat with roles increasingly combining consulting and sales functions. PharmaForce International also published a similar Oncology benchmarking study for the United States in May 2023.PR NewswirePharmaForce International: US Oncology Companies Shift Toward Tumor-Specific Sales Channel AlignmentsPharmaForce International published a competitive intelligence report benchmarking commercial operations and marketing expenditures of leading Oncology Sales and Marketing organizations in the United States. The key finding shows several profiled companies have re-aligned their sales operations to a tumor-centric model, providing oncology and hematology healthcare professionals with direct access to field-based industry subject-matter experts and tumor-specific triage to specialized personnel. In addition to the US study, PFI is conducting similar oncology benchmarking reports across the five major European countries, with EU5 reports expected by July 2022.PR NewswirePharmaForce International: US Immunology Market Sees Significant Changes to Sales ApproachesPharmaForce International published a benchmark report on leading US Immunology sales and marketing organizations in February 2022, covering companies with products in Dermatology, Gastroenterology, and Rheumatology markets throughout 2021. The report found that at least half of companies in the Immuno-inflammation space made significant changes to their Sales FTE approaches, including restructured field sales teams, new business units, FTE consolidations, and layoffs. These modifications are attributed to increased focus on Dermatology indications such as Atopic Dermatitis and Plaque Psoriasis, upcoming biosimilar launches, and continued COVID-19 impacts on the sector.PR NewswirePharmaForce International: Neurology Sales Representatives Continue to Encounter Larger Restrictions with HCP InteractionsPharmaForce International published benchmarking reports covering three Neurology areas in the United States for 2021, focusing on Migraine, Multiple Sclerosis, and Parkinson's and Alzheimer's Diseases. The reports found that COVID-19 has continues to restrict face-to-face interactions for Neurology sales representatives, as neurology practices, hospitals, and long-term facilities maintain stricter access policies compared to Primary Care. Representatives report completing fewer speaker dinner programs, with some programs fully virtual or not held at all, making it difficult to reach sales budgets as markets have not recovered from pandemic-era disruptions.PR NewswirePharmaForce International: Immunology Benchmarking Study Captures Key Increases in FTEs by Indication in EuropePharmaForce International released findings from its EU5 Immunology benchmarking study covering France, Germany, Italy, Spain, and the United Kingdom. The study identified notable increases in full-time equivalents dedicated to specific immunology indications, including over 40% growth in Atopic Dermatitis FTEs in Spain and the UK, and over 60% growth in Ulcerative Colitis FTEs in Italy since the previous 2020 report. The company noted these FTE increases occurred despite limited newly approved products entering the market, and a separate US Immunology report is scheduled for December 2021.PR NewswirePharmaForce International: Leading US Oncology Companies Modify Their Field Sales Metrics to Accommodate the Changing MarketPharmaForce International (PFI) published a benchmarking report profiling over 40 leading Oncology Sales and Marketing organizations in the United States, documenting how these companies adapted their commercial approaches during the COVID-19 pandemic. The report found that companies modified sales metrics, quotas, and shifted to virtual HCP interactions, with 24 new product launches identified and at least 15 active co-promotes observed. PFI has also completed similar oncology benchmarking reports for Europe (France, Germany, Italy, Spain, and United Kingdom) and expects to release the Japan report by the end of July.PR NewswirePharmaForce International: Research Captures United States Pharma Companies' Best COVID-19 ApproachesPharmaForce International has released a report on how US pharmaceutical and biotech companies adapted their field operations during the COVID-19 pandemic, based on over 150 interviews conducted between March and December 2020. The report found that sales representatives significantly increased virtual interactions with healthcare providers while face-to-face engagements declined. The research indicates that approximately 30-40% of healthcare providers are still not seeing sales representatives in person or virtually, with sales reps averaging only 1-2 calls per day since March 2020.PR NewswirePharmaForce International: Updated User-Friendly Dashboard Allows for Five Year Trending of Oncology Commercialization FTEsPharmaForce International has updated its US Oncology trends dashboard, enabling competing oncology companies to compare commercial full-time equivalents across over 70 indications from 2016 to 2020 for strategic planning purposes. The dashboard allows users to sort data by year, company, product, and indication, including CAR-T and biomarker/pathology FTE breakdowns. PFI has also launched a similar Oncology trends dashboard covering the five major European countries (France, Germany, Italy, Spain, and the United Kingdom), now available for purchase.PR NewswirePharmaForce International: Leading EU5 Oncology Companies Adopt New Commercial Trends During the Time of COVID-19PharmaForce International released its 2020 benchmarking report covering oncology sales and marketing organizations across France, Germany, Italy, Spain, and the United Kingdom, identifying how leading pharmaceutical companies adapted commercial operations during the COVID-19 pandemic. Key findings include the halt of field promotions between March and June in France, a shift to digital communication platforms such as phone, web, and video calls across markets, and delays in product launches and approvals. The report also notes emerging trends including increased partnering to test PD-L1 drug combinations, growth in CAR-T cell therapy approvals and development, and new business units created in Italy specifically to promote these products.PR NewswirePharmaForce International: MSL Engagement Tactics for Leading US Pharmaceutical Companies Continue to Change DramaticallyPharmaForce International completed primary research on US pharmaceutical companies' field medical affairs strategies, finding significant shifts in engagement tactics. Leading pharmaceutical companies have increased investment in field medical affairs, particularly Medical Science Liaisons and payer-facing roles, while traditional sales channel outreach has plateaued. The shift has been accelerated by COVID-19, with companies adopting virtual tools and innovative engagement concepts to maintain momentum with healthcare professionals and organized customers.